VANCOUVER, BC / ACCESSWIRE / August 8th, 2017 / CVR Global Inc., on behalf of CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) has signed a letter of intent with Canon Virginia, Inc. (CVI),
VANCOUVER, BC / ACCESSWIRE / June 29, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that Thomas Jefferson University Hospital – Jefferson Clinical Research Institute has issued an
VANCOUVER, BC / ACCESSWIRE / June 2, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that CVR Medical has obtained TSX Venture Exchange approval to issue 243,850 common
VANCOUVER, BC / ACCESSWIRE / May 25, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce an update of its clinical trials of the “Carotid Stenotic Scan (CSS),” being
VANCOUVER, BC / ACCESSWIRE / May 12, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) had entered into a consulting agreement with Lubow Group (“Lubow”), a Florida Sole Proprietorship, with an effective
VANCOUVER, BC / ACCESSWIRE / April 25, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces update on clinical trials of the “Carotid Stenotic Scan (CSS),” currently being conducted through the Jefferson
VANCOUVER, BC / ACCESSWIRE / April 24, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to report that it has closed the second and final tranche (the “Second Tranche“) of
VANCOUVER, BC / ACCESSWIRE / April 20, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to report that it has closed the first tranche (the “First Tranche“) of its previously
VANCOUVER, BC / ACCESSWIRE / March 29, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) previously announced its intention to complete a private placement financing of units for gross proceeds of up
VANCOUVER, BC / ACCESSWIRE / March 20, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) a leading research and development company aiming to make arterial diagnostic testing significantly more accessible with its
VANCOUVER, BC / ACCESSWIRE / March 16, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces partnership with ADCO Circuits, a Michigan-based electronic design and manufacturing company. ADCO will
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.